Kidney cancer originates from kidney tissue and, when detected early, can be successfully treated with surgery. The tumor's size, location and extent are the key factors in determining the treatment method to be used.
In selected patients, robotic surgery is considered a modern, minimally invasive approach for the surgical treatment of kidney cancer. This method offers high-precision surgical capabilities that allow preservation of kidney tissue and surrounding anatomical structures.
Diagnosing kidney cancer involves evaluating the patient's clinical findings, imaging and necessary laboratory tests together. Computed tomography and magnetic resonance imaging analyze the tumor's size, its position within the kidney and its relationship to surrounding tissue in detail.
This evaluation guides the suitability of robotic surgery and the scope of the surgical plan.
Robotic surgery for kidney cancer allows precise intervention thanks to high-resolution 3D visualization and enhanced surgical dexterity. Depending on the tumor's characteristics, either the whole kidney, or in suitable cases only the tumor-bearing part, can be planned for removal.
The robotic approach can provide advantages such as preserving surrounding tissue, less bleeding and a faster recovery. With proper patient selection, safe and effective surgical results are the aim.
After surgery, patients are placed on a regular follow-up program. The function of the remaining kidney, general health and oncologic surveillance are closely assessed. Additional treatment or supportive approaches may be planned if needed.
The main goal of the treatment process is to control the disease, preserve kidney function and maintain the patient's quality of life.
